Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ddf555
    Junior Member
    • Oct 2013
    • 1

    #1

    DESeq power calculation

    We're trying to calculate the effect size cutoff for a given power — in this case we have 4 naïve samples, 4 experiment samples, and we're using DESeq for the differential expression analysis.

    So running these parameters through a power calculator -- we're leaving delta empty, so the system can tell us what the effect size should be.

    pwrCalc<-power.t.test(n=4,sig.level=0.01,power=0.9,sd=???,delta=NULL)

    So, the question is how do we get the sd out of DESeq — with that, we can calculate the delta that is required for a power 0.9 and sig level of 0.01.

    Please let us know if anyone has a suggestion, or if there's a different way to calculate the power, or if we're thinking about this wrong. Thanks!
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    The variance is mean dependent and, anyway, this would only give you power for one gene. Further, you appear to be calculating post-hoc power, which is typically meaningless. The question you have to ask is what you're trying to achieve. Typically, you want to know how many samples you would need to have a reasonable power of finding reasonable magnitude fold-changes, for which tools such as Scotty would seem relevant.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Working...